An essential role for nuclear factor kappa B in preventing TNF-α-induced cell death in prostate cancer cells

Journal of Urology

Volumn 161, Issue 2, 1999, Pages 674-679

  Sumitomo, Makoto ^a   Tachibana, Masaaki ^b   Nakashima, Jun ^b   Murai, Masaru ^b   Miyajima, Akira ^b   Kimura, Fumihiro ^b   Hayakawa, Masamichi ^b   Nakamura, Hiroshi ^b  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b NONE

Author keywords

Apoptosis; NF B; Prostate cancer; TNF

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL DIVISION; DRUG ANTAGONISM; HUMAN; MALE; PATHOLOGY; PHYSIOLOGY; PROSTATE TUMOR;

APOPTOSIS; CELL DIVISION; HUMANS; MALE; NF-KAPPA B; PROSTATIC NEOPLASMS; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033072728     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0022-5347(01)61993-1     Document Type: Article

References (36)

1. Vassalli, P.: The pathophysiology of tumor necrosis factors. Ann. Rev. Immunol., 10: 411, 1992.
2. Loetscher, H., Pan, Y-C. E., Lahm, H-W., Gentz, R., Brockhaus, M., Tabuchi, H. and Lesslauer, W.: Molecular cloning and expression of the human 55 kDa tumor necrosis factor receptor. Cell, 61: 351, 1990.
3. Schall, T. J., Lewis, M., Koller, K. J., Lee, A., Rice, G. C., Wong, G. H. W., Gatanaga, T., Granger, G. A., Lentz, R., Raab, H., Kohr, W. J. and Goeddel, D. V.: Molecular cloning and expression of a receptor for human tumor necrosis factor. Cell, 61: 361, 1990.
4. Smith, C. A., Davis, T., Anderson, D., Solam, L., Beckmamm, M. P., Jerzy, R., Dower, S. K., Cosman, D. and Goodwin, R. G.: A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. Science, 248: 1019, 1990.
5. Sugarman, B. J., Aggarwal, B. B., Hass, P. E., Figari, I. S., Palladino, M. A., Jr. and Shepard, H. M.: Recombinant human tumor necrosis factor a: effects on proliferation of normal and transformed cells in vitro. Science, 230: 943, 1988.
6. Nakajima, Y., DelliPizzi, A., Mallouh, C. and Ferreri, N. R.: TNF-mediated cytotoxicity and resistance in human prostate cancer cells. Prostate, 29: 296, 1996.
7. Okamoto, T., Watanabe, N., Yamauchi, N., Tsuji, Y., Tsuji, N., Itoh, Y., Neda, H. and Nittsu, Y.: Endogenous tumor necrosis factor exerts its protective function intracellularly against the cytotoxicity of exogenous necrosis factor. Cancer Res., 52: 5278, 1992.
8. Safrit, J. T. and Bonadiva, B.: Sensitivity of resistant human tumor cell lines to tumor necrosis and adriamycin used in combination: correlation between down-regulation of tumor necrosis factor-messenger RNA induction and overcoming resistance. Cancer Res., 52: 6630, 1992.
9. Defilippi, P., Poupart, P., Tavernier, J., Fiers, W. and Content, J.: Induction and regulation of mRNA encoding 26-kDa protein in human cell lines treated with recombinant human tumor necrosis factor. Proc. Natl. Acad. Sci. USA, 84: 4557, 1987.
10. Wong, G. H. W., Elwell, J. H., Oberley, L. W. and Goeddel, D. V.: Manganous Superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor. Cell, 58: 923, 1989.
11. Beg, A. A. and Baltimore, D.: An essential role for NF-κB in preventing TNF-α-induced cell death. Science, 274: 782, 1996.
12. Wang, C-Y., Mayo, M. W. and Baldwin, A. S., Jr.: TNF- and cancer therapy-induced apoptosis.: Potentiation by inhibition of NF-κB. Science, 274: 784, 1996.
13. Van Antwerp, D. J., Martin, S. J., Kafri, T., Green, D. R. and Verma, I. M.: Suppression of TNF-α-induced apoptosis by NF-κB. Science, 274: 787, 1996.
14. Baeuerle, P. A. and Henkel, T.: Function and activation of NF-κB in the immune system. Annu. Rev. Immunol., 12:141, 1994.
15. Wu, M., Lee, H., Bellas, R. E., Schauer, S. L., Arsura, M., Katz, D., FitzGerald, M. J., Rothstein, T. L., Sherr, D. H. and Sonenshein, G. E.: Inhibition of NF-κB /Rel induces apoptosis of murine B cells. EMBO J., 15: 4682, 1996.
16. Lopez Lopez, R., van Rijswijk, R. E. N., Wagstaff, J., Pinedo, H. M. and Peters, G. J.: The synergistic and antagonistic effect of cytotoxic and biological agents on the in vivo antitumour effect of suramin. Eur. J. Cancer, 30A: 1545, 1996.
17. Sokoloff, M. H., Tso, C.-L., Kaboo, R., Taneja, S., Pang, S., deKernion, J. B. and Belldegrun, A. S.: In vitro modulation of tumor progression-associated properties of hormone refractory prostate carcinoma cell lines by cytokines. Cancer, 77: 1862, 1996.
18. Borsellino, N., Belldegrun, A. and Bonavida, B.: Endogenous interleukin 6 is a resistance factor for cis-diamminedichloroplatinum and etoposide-mediated cytotoxicity of human prostate carcinoma cell lines. Cancer Res., 55: 4633, 1995.
19. Okamoto, M., Lee, C. and Oyasu, R.: Interleukin-6 as a paracrine and autocrine growth factor in human prostatic carcinoma cells in vitro. Cancer Res., 57: 141, 1997.
20. Greene, G. F., Kitadai, Y., Pettaway, C. A., von Eschenbach, A. C., Bucana, C. D. and Fidler, I. J.: Correlation of metastasis-related gene expression with metastatic potential in human prostate carcinoma cells implanted in nude mice using an in situ messenger RNA hybridization technique. Am. J. Pathol., 150: 1571, 1997.
21. Lang, S. H., Miller, W. R., Dunkan, W. and Habib, F. K: Production and response of human prostate cancer cell lines to granulocyte macrophage-colony stimulating factor. Int. J. Cancer, 59: 235, 1994.
22. Rokhlin, O. W., Griebling, T. L., Karassina, N. V., Raines, M. A. and Cohen, M. B.: Human prostate carcinoma cell lines secrete GM-CSF and express GM-CSF-receptor on their cell surface. Anticancer Res., 16: 557, 1996.
23. Rokhlin, O. W. and Cohen, M. B.: Expression of cellular adhesion molecules on human prostate tumor cell lines. Prostate, 26: 205, 1995.
24. Schutze, S., Potthoff, K., Machleidt, T., Berkovic, D., Weigmann, K. and Kronke, M.: TNF activates NF-κB by phosphatidylcholine-specific phospholipase C-induced "acidic" sphingomyelin breakdown. Cell, 71: 765, 1992.
25. Pushkareva, M., Obeid, L. and Hannun, Y. A.: Ceramide: an endogenous regulator of apoptosis and growth suppression. Immunol. Today, 16: 294, 1995.
26. Obeid, L. M., Linardic, C. M., Karolak, L. A. and Hannun, Y. A.: Programmed cell death induced by ceramide. Science, 259: 1769, 1993.
27. Hsu, H., Xiong, J. and Goeddel, D. V.: The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation. Cell, 81: 495, 1995.
28. Hsu, H., Shu, H-B., Pan, N-G. and Goeddel, D. V.: TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell, 84: 299, 1996.
29. Schreck, R., Meier, B., Mannel, D. N. and Droge, W.: Dithiocarbamates as potent inhibitors of nuclear factor êÂin intact cells. J. Exp. Med., 175: 1181, 1992.
30. Traenckner, E. B-M., Wilk, S. and Baeuerle, P. A.: A proteasome inhibitor prevents activation of NF-κB and stabilizes a newly phosphorylated form of IκB -α that is still bound to NF-κB. EMBO J., 13: 5433, 1994.
31. Bessho, R. Matsubara, K., Kubota, M., Kuwakado, K., Hirota, H., Wakazono, Y., Lin, Y. W., Okuda, A., Kawai, M., Nishikomori, R. and Heike, T.: Pyrrolidine dithiocarbamate, a potent inhibitor of nuclear factor κB (NF-κB) activation, prevents apoptosis in human promyelocytic leukemia HL-60 cells and thymocytes. Biochem. Pharmacol., 48: 1883,1994.
32. Shenk, H., Klein, M., Erdburgger, W., Droge, W. and Schulze-Osthoff, K.: Distinct effects of thioredoxin and antioxidants on the activation of transcription factors NF-κB and AP-1. Proc. Natl. Acad. Sci. USA., 91: 1672, 1994.
33. Mayo, M. W., Wang, C-Y., Cogswell, P. C., Rogers-Graham, K. S., Lowe, S. W., Der, C. J. and Baldwin, A. S., Jr.: Requirement of NF-κB activation to suppress p53-independent apoptosis induced by oncogenic Ras. Science, 278: 1812, 1997.
34. Herrmann, J. L., Beham, A. W., Sarkiss, M., Chiao, P. J., Rands, M. D., Bruckheimer, E. M., Brisbay, S. and McDonnell, T. J.: Bcl-2 suppress apoptosis resulting from disruption of the NF-κB survival pathway. Exp. Cell Res., 237: 101, 1997.
35. Nakshatri, H., Bhat-Nakshatri, P., Martin, D. A., Goulet, R. J. Jr. and Sledge, G. W. Jr.: Constitutive activation of NF-κB during progression of breast cancer to hormone-independent growth. Mol. Cell. Biol., 17: 3629, 1997.
36. Slater, A. F. G., Kimland, M., Jiang, S. A. and Orrenius, S.: Constitutive nuclear NF-KB/rel DNA-binding activity of rat thymocytes is increased by stimuli that promote apoptosis, but not inhibited by pyrrolidine dithiocarbamate. Biochem. J., 312: 833, 1995.